Compare Autodesk Inc (ADSK) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Autodesk Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Autodesk Inc trades at $206.41 (market cap $44.84B), while Regeneron Pharmaceuticals Inc trades at $662.85 (market cap $70.90B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Autodesk Inc pays none. Which is the better fit depends on your goals.
| ADSK | REGN | |
|---|---|---|
Market Cap | $44.84B | $70.90B |
Sector | Technology | Health |
52-Week High | $326.79 | $812.27 |
52-Week Low | $187.72 | $542.52 |
Enterprise Value | $44.64B | $64.85B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Autodesk Inc
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
